There are 30+ gene therapies approved across medicine. ABBV-RGX-314 is targeting wet AMD and is in global pivotal trials with positive preliminary trials to date, thanks @JasonHsuMD #RSLisbon2024 @Wills_Eye @MidAtl_Retina @REGENXBIO @abbvie

And the first Eyecelerator Innovation Awardees are .... Join us in Chicago @aao_ophth @Eyecelerator 2024 to learn the story of two of the most innovative and admired pharmaceutical leaders in the world and their vision of a brighter future for our patients

🌿📜 And lo, Slothana, in its eternal wisdom and benevolence, hath decreed: 'Behold, there are but twelve days remaining until the dawn of a new era.' 🚀 Let us prepare our hearts and minds, for the age of Slothana draws near. May the gains and Lambos be bestowed upon us all.

🌿💰 Prepare for the rise of Slothana! With our coffers overflowing, it's time to embark on a Sloth crusade to establish a global empire. Slothana's reign is imminent. ⚔️ Anyone who stands in its way will face the wrath of the holy Slothana army! 🚀🦥 #SlothanaEmpire

🚀 Exciting news for our lazy sloth community! Our airdrop is being prepped for launch, which means the presale is wrapping up soon. ⏳ With Solana congestion expected to end in the coming days, now's the time to join the holy Slothana army!🌿💸 #SlothanaAirdrop #PresaleEnding

🚀 Hold onto your branches, Slothana faithful! 🌿 We're gearing up to drop some major news: the official launch date is on the horizon! ⏰ Get ready to mark your calendars and set your alarms, because a countdown timer will soon grace our site. Let the hype for the Slothana

@Dr_ZebaSyed

In eyes with primary rhegmatogenous retinal detachment & high risk features for postoperative proliferative vitreoretinopathy, repair with combined vitrectomy & scleral buckling resulted in a higher odds of surgical success. @KhanRetina https://t.co/XqtPwGOsM2

We fix it front to back @Wills_Eye. Knew from our med school days (rugby field!) that Dr Rapuano would lead others and do great things. Congratulations to our expert colleagues of the Wills Cornea Sevice @Cjrapuano @zeba_almas @BeeranMeghpara @bfast33 @JuliaHallerMD

"It’s an incredibly important time for us and our patients," says Allen Ho, MD @allenho in a Retina Today interview where he shares his insights on caring for a whole new patient population with newly approved therapeutics.

Takes a village to #eliminateDRblindnessPhilly #scheieeye #templeophthalmology #willseye #midatlanticretina #jeffersonmed . We are going for it together #noeyeslostPhilly

Data science expert Dr Michael Morano lead our team @MMoranoMD, amazing skill set … there is a very bright future for Michael!

Incidence and Risk Factors for Retinal Detachment and Retinal Tear aft... https://t.co/Jv5Bk9Cl6i This IRIS study of over 3 million cataract surgeries reveals that the incidence of retinal detachment after cataract surgery is 1/500. Lattice degeneration is the top risk factor.

Diabetic eye disease is the #1 cause of blindness in working age adults. Sign up to get your FREE diabetic eye disease screening at Wills Eye Hospital on April 29. Don't wait.

VBS meetings showcase great scientific and clinically relevant programming and incredibly aggressive and creative social events, great learning and a great time @YoshiYonekawaMD @VitBuckleSoc

FDA Approves Syfovre for Geographic Atrophy with commentary by Allen Ho, MD @allenho. Listen to the full podcast episode here -

Are you ready for the era of GA treatment? 🎧Tune into the latest New Retina Radio podcast to hear Drs. @allenho & Robert Avery discuss the recent FDA approval of pegcetacoplan (Syfovre, @ApellisPharma) & what it means for patient care & clinical practice.

https://t.co/tFLaEg6N3x

Retinal surgery continues to evolve, check it out